Gynaecological clinical trials

Explore recruiting gynaecological clinical trials.

Recruiting gynaecological studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gynaecological trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy, safety, and dose-response of a Live Biotherapeutic Product (BGY-1601-VT, vaginal tablet) as a first-line monotherapy in women with acute vaginal infection: a randomized, double-blind, placebo-controlled study

France, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGN151 (anti-FRα antibody-drug conjugate) in Adult Patients with Recurrent Gynaecological Cancers

Germany, Ireland, Belgium, Spain, Italy, France +1 more

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

HPV2-2303 - Phase 2 clinical trial evaluating secondary HPV vaccination after treatment of high-grade cervical lesions

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.

Hungary, Poland, Spain, Czechia, Germany, Lithuania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent Ovarian Cancer.

Netherlands, Finland, Norway, Lithuania, Austria, Germany +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.

Germany, Hungary, Czechia, Poland, Spain, Lithuania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gynaecological trials by city

Gynaecological in Toronto Gynaecological in Vancouver Gynaecological in Montreal Gynaecological in Calgary Gynaecological in Edmonton Gynaecological in Ottawa Gynaecological in Winnipeg Gynaecological in Quebec City Gynaecological in Hamilton Gynaecological in Kitchener Gynaecological in London Gynaecological in Halifax Gynaecological in New York Gynaecological in Los Angeles Gynaecological in Chicago Gynaecological in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease